Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4205776
Max Phase: Preclinical
Molecular Formula: C96H122N34O16
Molecular Weight: 2008.25
Molecule Type: Unknown
Associated Items:
ID: ALA4205776
Max Phase: Preclinical
Molecular Formula: C96H122N34O16
Molecular Weight: 2008.25
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(CCCN)CCCNC(=O)CCNC(=O)c1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4cc(NC(=O)CCNC(=O)c5cc(NC(=O)c6cc(NC(=O)CCCNC(=O)c7cc(NC(=O)c8cc(NC(=O)c9cc(NC(=O)CCNC(=O)c%10cc(NC(=O)c%11cc(NC(=O)c%12nc(N=C(N(C)C)N(C)C)cn%12C)cn%11C)cn%10C)cn9C)cn8C)cn7C)cn6C)cn5C)cn4C)cn3C)cn2C)cn1C
Standard InChI: InChI=1S/C96H122N34O16/c1-116(2)96(117(3)4)115-78-55-130(17)83(114-78)95(146)113-66-43-77(129(16)54-66)94(145)109-62-39-70(122(9)50-62)87(138)102-30-24-82(134)104-57-34-72(124(11)45-57)89(140)110-63-40-74(126(13)51-63)91(142)107-59-36-67(119(6)47-59)84(135)99-26-18-21-80(132)103-56-33-71(123(10)44-56)88(139)106-60-38-69(121(8)48-60)86(137)101-29-23-81(133)105-58-35-73(125(12)46-58)90(141)111-64-41-76(128(15)52-64)93(144)112-65-42-75(127(14)53-65)92(143)108-61-37-68(120(7)49-61)85(136)100-28-22-79(131)98-27-20-32-118(5)31-19-25-97/h33-55H,18-32,97H2,1-17H3,(H,98,131)(H,99,135)(H,100,136)(H,101,137)(H,102,138)(H,103,132)(H,104,134)(H,105,133)(H,106,139)(H,107,142)(H,108,143)(H,109,145)(H,110,140)(H,111,141)(H,112,144)(H,113,146)
Standard InChI Key: BYRJDEYUSLUNTP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 2008.25 | Molecular Weight (Monoisotopic): 2006.9778 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Castaneda CH, Scuderi MJ, Edwards TG, Harris GD, Dupureur CM, Koeller KJ, Fisher C, Bashkin JK.. (2016) Improved Antiviral Activity of a Polyamide Against High-Risk Human Papillomavirus Via N-Terminal Guanidinium Substitution., 7 (11): [PMID:27840672] [10.1039/C6MD00371K] |
Source(1):